BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen H, Isenberg DA. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome. Blood 2021;137:299-309. [PMID: 32898856 DOI: 10.1182/blood.2020004942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tumian NR, Hunt BJ. Clinical Management of Thrombotic Antiphospholipid Syndrome. JCM 2022;11:735. [DOI: 10.3390/jcm11030735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Selby R, Abdulrehman J. Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic. J Appl Lab Med 2022;7:373-8. [PMID: 34996086 DOI: 10.1093/jalm/jfab134] [Reference Citation Analysis]
3 Croles FN, Te Boekhorst PAW, Leebeek FWG, Jansen AJG. Therapeutic plasma exchange for anticoagulant-refractory antiphospholipid syndrome with severe ischemic and necrotic skin lesions: A case series. Transfus Apher Sci 2021;:103192. [PMID: 34226147 DOI: 10.1016/j.transci.2021.103192] [Reference Citation Analysis]
4 Ghembaza A, Saadoun D. Management of Antiphospholipid Syndrome. Biomedicines 2020;8:E508. [PMID: 33212808 DOI: 10.3390/biomedicines8110508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Erkan D. Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome. Arthritis Rheumatol 2021. [PMID: 34114366 DOI: 10.1002/art.41891] [Reference Citation Analysis]
6 Xourgia E, Tektonidou MG. An Update on Antiphospholipid Syndrome. Curr Rheumatol Rep 2022;23:84. [PMID: 34985625 DOI: 10.1007/s11926-021-01051-5] [Reference Citation Analysis]